STOMPing forward: statins, muscle complaints and CK.
Zora Biosciences, Biologinkuja 1, 02150 Espoo, Finland; Science Center, Tampere University Hospital, Tampere, Finland. Electronic address: reijo.laaksonen@helsinki.fi.
Reijo
R
Laaksonen
D050197:Atherosclerosis / Q000473:pathology; D000069059:Atorvastatin; D003402:Creatine Kinase / Q000378:metabolism*; D006538:Heptanoic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D018908:Muscle Weakness / Q000139:chemically induced*; D018482:Muscle, Skeletal / Q000473:pathology; D009132:Muscles / Q000187:drug effects / Q000473:pathology*; D009135:Muscular Diseases / Q000473:pathology*; D063806:Myalgia / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D003402:Creatine Kinase
Creatine kinase; Muscle function; Muscle pain; Myopathy; Statins